AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

17,21,22 Tezspire is approved in the US, the EU and nearly 60 countries for the add-on maintenance treatment of adult and ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

As pollution levels soar, the impact on children's health goes beyond physical illnesses, creeping into aspects of learning ...

We expect to report top-line data from our ongoing Phase 2 clinical trials in severe asthma and chronic rhinosinusitis with nasal polyps in the second ... which will support our strategy of leveraging ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

Unlike the common cold—which, although miserable, usually doesn't hurt anyone—influenza can be serious business. Here's what ...

Five climate risks veterinarians want you to know about, so you can protect your furry friends from the climate crisis.